PAMS
LGND icon

Pictet Asset Management (Switzerland)’s Ligand Pharmaceuticals LGND Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$8.2M Buy
113,721
+23,854
+27% +$1.79M 0.01% 662
2023
Q1 		$6.61M Buy
+89,867
New +$6.39M 0.01% 718

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s LGND Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Ligand Pharmaceuticals (LGND) stake by 27% in Q2 2023, buying an estimated $1.79M and bringing the position to 113,721 shares worth $8.2M. The position accounts for 0.01% of the portfolio, ranked #662.

Pictet Asset Management (Switzerland) first reported a position in LGND in Q1 2023 and has held it in 2 quarters since. 204 funds tracked by Wall St. Rank hold LGND as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 113,721 shares of Ligand Pharmaceuticals worth $8.2M as of Q2 2023.
  • Pictet Asset Management (Switzerland) bought 23,854 Ligand Pharmaceuticals shares in Q2 2023, an estimated $1.79M.
  • Ligand Pharmaceuticals made up 0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #662 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Ligand Pharmaceuticals in Q1 2023 and has held it in 2 quarters since.
  • 204 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.